In contrast, certain cohorts, such as the study conducted at the Memorial Sloan Kettering Cancer Center involving 243 MSH6 and PMS2 carriers, emphasize a younger age at diagnosis of CRC, with a median age of 51.5 years (range 27–80). The gene discussed is MSH6; the disease is colorectal carcinoma.